News & Updates

HPV infection ups risk of new-onset hidradenitis suppurativa

05 Mar 2025

Infection with the human papillomavirus (HPV) contributes to an increased risk of developing hidradenitis suppurativa (HS), indicating a potential association, reveals a study.

HPV infection ups risk of new-onset hidradenitis suppurativa

05 Mar 2025

Shorter duration, larger lesion predict treatment failure with 5-FU 5% cream

05 Mar 2025

Treatment with 5-fluorouracil (5-FU) 5% cream tends to end in failure with shorter treatment duration and larger lesion size in patients with squamous cell carcinoma in situ (SCCis), a study has shown.

Shorter duration, larger lesion predict treatment failure with 5-FU 5% cream

05 Mar 2025

Dietary fibre, probiotics: Allies in the fight against eczema and allergies

22 Feb 2025 by

A diet rich in fibre appears to offer some protection against atopic dermatitis and a common allergy triggered by house dust mites in Asians, with the risks further mitigated by combining dietary fibre with probiotics, as reported in a study.

Dietary fibre, probiotics: Allies in the fight against eczema and allergies

22 Feb 2025

Pandemic babies have a 46 percent higher risk of atopic diseases

05 Feb 2025 by

The incidence of atopic diseases in infants born in Hong Kong has increased by 46 percent during the COVID-19 pandemic, potentially linked to altered neonatal microbiome diversity resulting from vigorous disinfection. SIM03 and SIM05, symbiotic formulae developed with the aid of artificial intelligence (AI), are shown to improve eczema severity and quality of life (QoL) in children and adults, respectively, by modulating gut microbiota.

Pandemic babies have a 46 percent higher risk of atopic diseases

05 Feb 2025

Dupilumab trumps MTX, cyclosporine in paediatric AD

03 Feb 2025 by

The use of dupilumab in children with moderate-to-severe atopic dermatitis (AD) results in greater improvements in AD severity, better adherence, and fewer treatment-emergent adverse events (TEAEs) than methotrexate (MTX) or cyclosporine, as shown by 2-year interim results from the PEDISTAD study.

Dupilumab trumps MTX, cyclosporine in paediatric AD

03 Feb 2025

Transdermal microneedle less painful vs intralesional injection in AA

03 Feb 2025

In the treatment of mild-to-moderate patchy alopecia areata (AA), microneedle transdermal delivery of compound betamethasone exhibits similar efficacy as the traditional intralesional injection and a significant reduction in pain, according to a study.

Transdermal microneedle less painful vs intralesional injection in AA

03 Feb 2025

Baricitinib plus phototherapy shows potential against extensive vitiligo

01 Feb 2025

Treatment with the combination of the small molecule Janus kinase 1/2 inhibitor baricitinib plus phototherapy may help reduce disease activity and induce repigmentation in adults with extensive and active nonsegmental vitiligo, according to the results of a phase II study.

Baricitinib plus phototherapy shows potential against extensive vitiligo

01 Feb 2025

Electrospun fibre patch to simplify psoriasis treatment

31 Jan 2025 by

A new patch that adheres to the skin and delivers two active ingredients holds promise in the treatment of psoriasis, reducing the need to apply topical medications to once a day and potentially improving adherence.

Electrospun fibre patch to simplify psoriasis treatment

31 Jan 2025

MAGIC database facilitates understanding of early-life gut microbiome dynamics

28 Jan 2025 by

The Metagenome-Assembled Genome Inventory for Children (MAGIC) database, which contains 20,172 global gut metagenomes from humans aged 0–7 years, characterizes the bacteriome and virome diversity of the global gut microbiome in early life.

MAGIC database facilitates understanding of early-life gut microbiome dynamics

28 Jan 2025

Isotretinoin for acne: Higher total dose exposure, lower relapse risk?

23 Jan 2025 by

A large cohort study suggests that for patients with acne who received an isotretinoin treatment course, the cumulative dosage taken, rather than the daily dose, is a key factor for reducing the risk of relapse and treatment retrial.

Isotretinoin for acne: Higher total dose exposure, lower relapse risk?

23 Jan 2025

News & Updates

Filter by Specialty:

Specialty:

HPV infection ups risk of new-onset hidradenitis suppurativa

HPV infection ups risk of new-onset hidradenitis suppurativa

Shorter duration, larger lesion predict treatment failure with 5-FU 5% cream

Shorter duration, larger lesion predict treatment failure with 5-FU 5% cream

Dietary fibre, probiotics: Allies in the fight against eczema and allergies

Dietary fibre, probiotics: Allies in the fight against eczema and allergies

Pandemic babies have a 46 percent higher risk of atopic diseases

Pandemic babies have a 46 percent higher risk of atopic diseases

Dupilumab trumps MTX, cyclosporine in paediatric AD

Dupilumab trumps MTX, cyclosporine in paediatric AD

Transdermal microneedle less painful vs intralesional injection in AA

Transdermal microneedle less painful vs intralesional injection in AA

Baricitinib plus phototherapy shows potential against extensive vitiligo

Baricitinib plus phototherapy shows potential against extensive vitiligo

Electrospun fibre patch to simplify psoriasis treatment

Electrospun fibre patch to simplify psoriasis treatment

MAGIC database facilitates understanding of early-life gut microbiome dynamics

MAGIC database facilitates understanding of early-life gut microbiome dynamics

Isotretinoin for acne: Higher total dose exposure, lower relapse risk?

Isotretinoin for acne: Higher total dose exposure, lower relapse risk?